
Spectrum Antimicrobials: Innovating non-antibiotic solutions for diverse infection control.
Founded with a mission to innovate non-antibiotic solutions for infection control, Spectrum Antimicrobials focuses on creating broad-spectrum chemistries to combat viral, bacterial, fungal, and mold infections. Their products are designed for use in wounds, surgical sites, eyes, body cavities, and lungs, aiming to address significant global healthcare challenges without causing resistance.
Notable figures affiliated with Spectrum Antimicrobials include a management team and a scientific advisory board comprised of experts in microbiology, chemistry, and toxicology. The company has achieved key milestones in developing effective non-antibiotic formulations, significantly impacting infection treatment and control. Their work represents a crucial advancement in addressing one of the most pressing issues in modern healthcare.

Prokaryotics
prokaryotics.com

Anti-Microbial Solutions

Microbion
microbioncorp.com

Mycologics
mycologics.net

Amicrobe
amicrobe.com

Antibiotic Adjuvant
a-adjuvant.com

Kathera Bioscience
katherabio.com

BioPlx

MiniVax

AvantGuard
avantguardinc.com

Bioharmony Therapeutics

ExoLytics
exolytics.com

PhagePro
phageproinc.com

Flightpath Biosciences
flightpath.bio

Innovative Biologics
Companies similar to Spectrum Antimicrobials include Prokaryotics, Anti-Microbial Solutions, Microbion and Mycologics.
Spectrum Antimicrobials was founded in 2016.
Spectrum Antimicrobials' headquarters is located in Petaluma, CA, US.
Spectrum Antimicrobials' most recent funding round was for $7.7M (USD) in April 2021.
As of Apr 1, 2021, Spectrum Antimicrobials has raised a total of $25.9M (USD).
Spectrum Antimicrobials has 30 employees as of Feb 5, 2024.